China National Accord Medicines Corp Ltd
SZSE:000028
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
CN |
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
21.4B CNY | 13.2 | |
US |
Mckesson Corp
NYSE:MCK
|
73.3B USD | 24.4 | ||
US |
Cencora Inc
NYSE:COR
|
44.1B USD | 23.8 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24B USD | 43.5 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 24.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
66.8B HKD | 6.9 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.6B EUR | 48.6 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.1B CNY | 19.4 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52.7B CNY | 13.9 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.